Recorded Chinese product: 复方四嗪利血平片复方四嗪利血平片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 河南省新谊药业股份有限公司Chinese legal name: 河南省新谊药业股份有限公司
主要成分Active Ingredients
- 胼屈嗪Pianqu Qin
- 环戊噻嗪Huanwu Saiqin
- 异丙嗪Yibing Qin
- 维生素BWeisheng Su
- 芦丁Lu Ding
- 氧化钾Yanghua Jia
- 氯喹Lv Kui
药物知识说明
胼屈嗪是一种在国家药监局注册认定的药品。该药品含有异丙嗪、氯喹、维生素b-210f1501等成分。
该药品关联的活性成分包括：异丙嗪Yibing Qin、氯喹Lv Kui、维生素b、芦丁Lu Ding。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：河南省新谊药业股份有限公司Chinese legal name: 河南省新谊药业股份有限公司。
您可以探索含有相同成分的其他药品：异丙嗪-0d3ed55b成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 复方四嗪利血平片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 异丙嗪Yibing Qin, 氯喹Lv Kui, 芦丁Lu Ding.
Manufacturers recorded for this product: 河南省新谊药业股份有限公司Chinese legal name: 河南省新谊药业股份有限公司.
Explore other medicines containing the same ingredient: 异丙嗪 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 复方四嗪利血平片Recorded Chinese product: 复方四嗪利血平片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 复方Recorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 河南省新谊药业股份有限公司Chinese legal name: 河南省新谊药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H41024405
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H41024405
Manufacturer
Chinese legal name: 河南省新谊药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H41024405
生产企业
河南省新谊药业股份有限公司(国产)
适应症
降压药。适用于各型高血压症。本品为多种降压镇静类药物的复合制剂，各种成分协同降压作用好。
用法用量
口服，一次1-2片，一日3次。血压降至正常后服维持量，一次1片，一日1次。
不良反应
1.利血平不良反应有过度镇静、注意力不集中、焦虑、抑郁、心律失常、心动过缓、眩晕、鼻塞及纳差、恶心等消化道症状。
2.盐酸肼屈嗪有头痛、恶心、心悸、心动过速、皮疹、免疫变态反应等。
3.利尿剂需注意水、电解质平衡失调，低钾、低钠、低氯。
禁忌
1.对本品成分过敏者禁用。
2.胃及十二指肠溃疡者禁用。
3.抑郁症患者禁用。
4.孕妇及哺乳期妇女禁用。
注意事项
慎用于体弱、老年、肾功能不全、心律失常及冠心病患者。运动员慎用
贮藏
遮光，密封，在阴凉干燥处（不超过20℃）保存。
规格
复方
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.